Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
LVMH Moët Hennessy Louis Vuitton S.A.

Start price
Target price
Perf. (%)
€681.60
26.01.22
€700.00
26.01.23
5.18%

Could be worthwhile Investment >10% per year
High dividend yield expected
Differentiated customer and product portfolio
Well known brand
buy
Standard Lithium Ltd

Start price
Target price
Perf. (%)
€5.35
25.01.22
€6.00
25.01.23
17.38%

Could be very worthwhile Investment >20% year
buy
Yooma Wellness Inc.

Start price
Target price
Perf. (%)
€0.087
24.01.22
€0.080
24.01.23
32.95%

Could be worthwhile Investment >10% per year
buy
Take-Two Interactive

Start price
Target price
Perf. (%)
€124.00
10.01.22
€140.00
10.01.23
13.83%

Could be worthwhile Investment >10% per year
BioNTech SE ADR

Start price
Target price
Perf. (%)
€253.50
20.12.21
€155.00
20.12.22
-45.27%

Moderna Inc.

Start price
Target price
Perf. (%)
€268.00
19.12.21
€135.00
19.12.22
-50.27%

Igm Biosciences Inc.

Start price
Target price
Perf. (%)
€25.40
14.12.21
€35.00
31.12.23
-39.76%

Could be very worthwhile Investment >20% year
buy
Arkema S.A.

Start price
Target price
Perf. (%)
€118.15
13.12.21
€125.00
13.12.22
8.46%

Could be worthwhile Investment >10% per year
buy
Bayer AG

Start price
Target price
Perf. (%)
€43.96
06.12.21
€48.00
12.10.22
19.15%

Could be worthwhile Investment >10% per year
Draftkings Inc.

Start price
Target price
Perf. (%)
€25.55
05.12.21
€22.00
05.12.22
-31.96%

Could be worthwhile Investment >10% per year
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
iBio Inc.

Start price
Target price
Perf. (%)
€0.61
05.12.21
€0.40
05.12.22
-38.15%

Revenue decline > 20% expected
EBIT decline/stagnation expected
Risky balance sheet
ROE lower than 10% per year
Jumia Technologies AG

Start price
Target price
Perf. (%)
€9.60
05.12.21
€8.00
05.12.22
-31.46%

Revenue growth >5% per year expected
Fair valuation
Probably not worthwhile Investment
EBIT decline/stagnation expected
buy
Molecular Partners AG

Start price
Target price
Perf. (%)
€12.20
02.12.21
€16.00
02.12.22
104.92%

Could be worthwhile Investment >10% per year
Odonate Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.44
01.12.21
€1.00
31.12.23
-31.60%

Could be very worthwhile Investment >20% year
Ocugen Inc.

Start price
Target price
Perf. (%)
€5.62
01.12.21
€4.00
31.12.23
-52.83%

Could be very worthwhile Investment >20% year
Krystal Biotech

Start price
Target price
Perf. (%)
€66.00
01.12.21
€50.00
31.12.23
-26.97%

Could be very worthwhile Investment >20% year
buy
GFT Technologies AG

Start price
Target price
Perf. (%)
€36.25
28.11.21
€39.00
28.02.22
11.17%

Risky Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Nel ASA

Start price
Target price
Perf. (%)
€1.73
27.11.21
€1.20
27.11.22
-33.83%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
Tesla Inc

Start price
Target price
Perf. (%)
€966.10
27.11.21
€760.00
27.11.22
-22.73%

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
High valuation
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€32.27
16.11.21
€25.00
16.11.22
-32.38%

Could be very worthwhile Investment >20% year
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€10.20
16.11.21
€11.00
31.12.24
8.82%

Could be very worthwhile Investment >20% year
buy
Lexibook

Start price
Target price
Perf. (%)
€4.03
15.11.21
€4.50
15.11.22
16.50%

Could be worthwhile Investment >10% per year
Oatly Group Ab

Start price
Target price
Perf. (%)
€10.80
14.11.21
€6.00
14.11.22
-48.01%

buy
Apple Inc.

Start price
Target price
Perf. (%)
€129.20
12.11.21
€140.00
12.11.22
10.57%

Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€9.23
09.11.21
€7.00
31.12.23
-28.96%

Could be very worthwhile Investment >20% year